LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 51 filers reported holding LEGEND BIOTECH CORP in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $3,655,741 | +65.4% | 82,541 | +109.5% | 0.00% | – |
| Q1 2024 | $2,209,834 | +16.5% | 39,398 | +25.0% | 0.00% | – |
| Q4 2023 | $1,896,138 | -13.4% | 31,513 | -3.3% | 0.00% | -100.0% |
| Q3 2023 | $2,190,078 | -17.9% | 32,605 | -15.6% | 0.00% | 0.0% |
| Q2 2023 | $2,667,181 | +716.4% | 38,638 | +470.3% | 0.00% | – |
| Q1 2023 | $326,691 | -70.3% | 6,775 | -74.9% | 0.00% | – |
| Q3 2022 | $1,100,000 | +22.6% | 26,972 | +65.3% | 0.00% | – |
| Q2 2022 | $897,000 | -79.5% | 16,313 | -86.5% | 0.00% | -100.0% |
| Q1 2022 | $4,385,000 | +7.1% | 120,698 | +37.4% | 0.00% | – |
| Q4 2021 | $4,094,000 | +625.9% | 87,822 | +687.1% | 0.00% | – |
| Q3 2021 | $564,000 | -58.4% | 11,158 | -66.3% | 0.00% | – |
| Q2 2021 | $1,357,000 | -63.8% | 33,086 | -74.4% | 0.00% | -100.0% |
| Q1 2021 | $3,752,000 | +99.6% | 129,302 | +192.7% | 0.00% | +100.0% |
| Q2 2020 | $1,880,000 | – | 44,171 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 560,506 | $26,125,000 | 18.14% |
| JOHNSON & JOHNSON | 1,629,173 | $75,936,000 | 8.64% |
| HHLR ADVISORS, LTD. | 11,804,925 | $550,228,000 | 8.50% |
| Paradigm Biocapital Advisors LP | 385,967 | $17,990,000 | 5.14% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,004,742 | $46,831,000 | 4.89% |
| Yong Rong (HK) Asset Management Ltd | 130,000 | $6,060,000 | 4.79% |
| Old Well Partners, LLC | 79,700 | $3,715,000 | 2.30% |
| TANG CAPITAL MANAGEMENT LLC | 200,000 | $9,322,000 | 1.88% |
| Tri Locum Partners LP | 89,840 | $4,187,000 | 1.65% |
| INDUS CAPITAL PARTNERS, LLC | 123,054 | $5,736,000 | 1.36% |